The High Cost of Drug Price Controls
Commentary By
The debate over expanding government control of our health sector should have ended during the COVID-19 pandemic:
Where there have been failures in responding to the crisis, it has been a failure of big government such as the Centers for Disease Control and Prevention’s arrogant and clumsy insistence on controlling early development of testing that delayed the U.S. response and surely cost lives. Or the failure to protect those most at risk, especially seniors in nursing homes. Or CDC’s decades-long refusal to develop a modern data tracking system.